Skip to content
Review Open access

Saccharin Revisited: Chemistry, Metabolism, Toxicology and Human Health Risk Assessment in the Era of Evidence-Based Food Safety.

Aug 2026 · Journal of Applied Toxicology · 0 citations · 145 references
Medicine

TL;DR

A comprehensive and critical synthesis of current knowledge on saccharin, encompassing its chemical characteristics, physicochemical properties, industrial and pharmaceutical applications, absorption, metabolism, excretion and toxicological profile is provided.

Abstract

Saccharin is one of the oldest and most extensively used nonnutritive sweeteners, valued for its intense sweetness, chemical stability and negligible caloric contribution. Since its discovery in 1879, it has been widely incorporated into foods, beverages, pharmaceuticals and personal care products, while its safety has remained the subject of considerable scientific and regulatory debate. Early experimental studies linking saccharin to bladder tumour formation in rodents raised concerns regarding its carcinogenic potential; however, subsequent mechanistic investigations, epidemiological evidence and comprehensive risk assessments have demonstrated that these findings are species-specific and not directly applicable to humans. This review provides a comprehensive and critical synthesis of current knowledge on saccharin, encompassing its chemical characteristics, physicochemical properties, industrial and pharmaceutical applications, absorption, metabolism, excretion and toxicological profile. Particular emphasis is placed on evaluating evidence related to carcinogenicity, genotoxicity, metabolic effects, oxidative stress, gut microbiota interactions and other emerging health concerns through the integration of experimental, clinical and population-based studies. In addition, the review examines the scientific basis of international regulatory decisions, discusses the challenges of translating animal toxicology findings into human health risk assessment and identifies persistent knowledge gaps requiring further investigation. Current evidence consistently supports the safety of saccharin when consumed within established acceptable daily intake limits established by international regulatory agencies. Nevertheless, well-designed long-term human studies and mechanistic investigations remain necessary to better define its potential effects on metabolic health, the gut microbiome and susceptible populations. By integrating historical evidence with contemporary advances in toxicology and regulatory science, this review provides an updated framework for understanding the safety, biological effects and public health implications of saccharin consumption.

Read PDF

Similar papers

Review Open access Sep 2026

Flavonoids: biological activities, nutritional and immunological aspects, therapeutic potential, food applications, and human health benefits—A comprehensive review

This comprehensive review summarizes current knowledge of flavonoids, including their classification into 14 main groups and their production via biosynthesis, chemical synthesis, modification, and extraction, and discusses potential drug interactions warranting clinical attention.

M. El-Saadony, A. Saad, Mohamed A. Fahmy et al. · 0 citations
Review Open access Aug 2026

Ergothioneine as an Emerging Food-Derived Bioactive Compound Protecting against Age-related Diseases: Issues Needing More Research.

Ergothioneine (ET) is a chemically-stable, tasteless, odourless, highly water-soluble diet-derived compound that is avidly absorbed and retained by the human body using a selective transporter, organic cation transporter novel 1, OCTN1 (often called the ET transporter, ETT). A substantial and growing body of evidence s...

B. Halliwell · 1 citation
Review Open access Aug 2026

Sucralose and Human Health: Metabolic, Microbiome, Neuroendocrine, Toxicological, and Environmental Perspectives

Sucralose is a prevalent non-nutritive sweetener characterised by its chemical stability, intense sweetness, and low-calorie content, which have facilitated its global acceptance, regulatory endorsement, and an acceptable daily intake (ADI) of 5 mg/kg. However, recent data question its presumed inertness and undersco...

A. Qadir, R. Omer · 0 citations
Review Open access Sep 2026

Food Safety Management and Mycotoxins Nexus: A Systematic Review of Mycotoxins Toxicity, Detoxification, Nutritional Impacts, and Economic Importance

This systematic review synthesizes evidence published from 2019 to 2026 on mycotoxin occurrence in food and feed, toxicological effects, nutritional consequences, economic implications, detection, and detoxification/mitigation strategies. The review followed PRISMA 2020 principles and included 141 publications after...

C. G. Awuchi · 0 citations
Review Open access Aug 2026

Nutraceutical and functional food: efficacy against metabolic disorders and underlying mechanistic insights.

BACKGROUND The growing global emphasis on health consciousness has significantly increased demand for traditional and complementary medicine products, including functional foods, nutraceuicals, and medicine and food homologous substances (MFHs). The rising prevalence of chronic diseases and the shift toward preventive...

Qi-Hui Yang, Y. Pei, Luyao Zhao et al. · 0 citations
Review Open access Sep 2026

Lichen-Derived Bioactive Compounds in Diabetes and Cardiovascular Risk: Experimental Evidence, Mechanisms, and Translational Challenges

Cardiometabolic disorders arise from interconnected metabolic, inflammatory, oxidative, mitochondrial, and vascular abnormalities. Lichens produce structurally diverse secondary metabolites, including depsides, depsidones, dibenzofurans, anthraquinones, and other phenolic compounds, whose experimental activities inters...

Alfredo Torres-Benítez, C. Acierno, Davide Nilo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.